The director, Charlotte Emery, has over 12 years experience working as a statistician - primarily for pharmaceutical companies but also in academia. She has experience in clinical trials across Phases 2-4 (including a regulatory submission) in a variety of therapeutic areas, especially oncology and respiratory.